Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PRIMO Health Partners vs Royal Medical Center

PRIMO Health Partners
Graded #481

Higher grade

vs+2.8999999999999986
Royal Medical Center
Graded #492

Lower grade

The verdict

PRIMO Health Partners takes it — 52.3/100 to 49.4/100.

PRIMO Health Partners grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PRIMO Health Partners is a telehealth practice offering virtual weight-loss consults with clinicians who prescribe GLP-1 medications, including semaglutide and tirzepatide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePRIMO Health Partners +23
45
22
Dose & formulationRoyal Medical Center +2
40
42
Clinical oversightPRIMO Health Partners +9
71
62
Labs & monitoringRoyal Medical Center +34
52
86
FulfillmentPRIMO Health Partners +7
55
48
Contract termsEven
55
55
PRIMO Health Partners · left barRoyal Medical Center · right bar

The numbers

MetricPRIMO Health PartnersRoyal Medical Center
WeighScore52.3/10049.4/100
GradeCC
Scorecard rank#481#492
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosed$450/mo (2.5 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
PRIMO Health Partners

Graded #481 · C

Strengths

  • Prescribes both semaglutide and tirzepatide after a virtual consult
  • Prescriptions can be routed to a pharmacy for either pickup or delivery
  • Two phone lines listed for support

Where it loses points

  • No pricing published on the site
  • States served and dispensing pharmacy are not disclosed
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard